cbdMD, Inc. (YCBD)

Every figure this model derived for YCBD, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 191,419 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 2,118,339 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 7,696,522 AssetsCurrent 2026-06-30
current liabilities 3,079,569 LiabilitiesCurrent 2026-06-30
equity 8,212,270 StockholdersEquity 2026-06-30
ocf -2,217,871 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 20,931,471 Revenues 2026-06-30
sbc 0 ShareBasedCompensation 2022-03-31

The ratios

The figures themselves rather than their scores — what somebody looking up YCBD on one particular measure came for.

RatioValue
cash operating margin-12.85
current ratio3.07
current ratio reported2.5
deferred revenue growth11.99
dilution pct647.25
fcf margin-11.51
operating margin-13.87
owner earnings margin-11.51
revenue growth10.01
revenue growth per share-85.28
roic-37.59
rule of 40-3.86
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about YCBD's figures. Written by the derivation as it ran, not added afterwards.